Most Read Articles
01 Sep 2015
Nasal steroids produced lower levels of improvement among patients with non-allergic rhinitis compared to those with allergic rhinitis as presented in a study.
20 Aug 2017
Increasing obstructive sleep apnoea (OSA) severity appears to have an independent association with retinal arteriolar narrowing and attenuated vascular pulsation amplitude, with the retinal vasculature a potential surrogate biomarker of cerebral and systemic vascular risk in patients with OSA, according to a study.
08 Jul 2015
Environmental factors, most especially mean vapor pressure, were substantially correlated with acute exacerbation of nonallergic rhinitis according to a study.
Pearl Toh, 13 May 2017
Short-term use of oral corticosteroids was associated with increased risks of adverse events such as fracture, sepsis, and venous thromboembolism (VTE), a large US cohort study showed.

New Product Highlight - Flutiform

22 Jun 2015
FLUTIFORM®– Fluticasone propionate and Formoterol fumarate Inhalation 50 mcg/5 mcg, 125 mcg/5 mcg and 250 mcg/10 mcg  
• flutiform® combines the ICS and LABA that doctors prefer:1,2
     - Well-tolerated and potent anti-inflammatory effects of fluticasone1-5
     - Fast onset and sustained bronchodilatory action of formoterol1-5
• flutiform® delivers a consistently high fine particle fraction across flow rates.6

References:
1. Price D, Bousquet J. Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma. Resp Med 2012; 106 (S1): S4-S8.
2.
Thomas M, Haughney J, Price D. Physicians’ attitudes towards combination therapy with inhaled corticosteroids and long-acting β2-agonist: an observational study in UK specialist care. Prag Obs Res 2011; 2: 25-31.
3. Flutiform® Approved Prescribing Information/Data Sheet.
4. Bodzenta-Lukaszyk A et al. Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatmentof asthma, but has a more rapid onset of action: an open-label, randomized study. BMC Pulm Med 2011; 11: 28-37.
5. Aalbers R et al. Onset ofbronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study. Adv Ther 2012; 29 (11):958-969.
6.
Johal B, Howald M, Fischer M, Marshall J. Comparison of the fine particle fraction of fluticasone propionate/formoterol fumarate combination with other combination products. Poster presented at the European Respiratory Society (ERS) 22nd Annual Congress, 1–5 September 2012, Vienna,Austria.

Further information available in Section 3b, New in This Issue and mims.com.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Sep 2015
Nasal steroids produced lower levels of improvement among patients with non-allergic rhinitis compared to those with allergic rhinitis as presented in a study.
20 Aug 2017
Increasing obstructive sleep apnoea (OSA) severity appears to have an independent association with retinal arteriolar narrowing and attenuated vascular pulsation amplitude, with the retinal vasculature a potential surrogate biomarker of cerebral and systemic vascular risk in patients with OSA, according to a study.
08 Jul 2015
Environmental factors, most especially mean vapor pressure, were substantially correlated with acute exacerbation of nonallergic rhinitis according to a study.
Pearl Toh, 13 May 2017
Short-term use of oral corticosteroids was associated with increased risks of adverse events such as fracture, sepsis, and venous thromboembolism (VTE), a large US cohort study showed.